These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 36370002)

  • 1. More costs than benefits from screening for cardiovascular disease with computed tomography in the DANCAVAS study.
    Andersen NH; Jørgensen T; Brodersen JB
    Eur Heart J; 2023 Jan; 44(1):68-69. PubMed ID: 36370002
    [No Abstract]   [Full Text] [Related]  

  • 2. Incidental detection in the DANCAVAS trial was limited by design and did not bias the cost effectiveness conclusion.
    Søgaard R; Diederichsen A; Lindholt J
    Eur Heart J; 2023 Jan; 44(1):70. PubMed ID: 36370030
    [No Abstract]   [Full Text] [Related]  

  • 3. The Danish Cardiovascular Screening Trial (DANCAVAS): study protocol for a randomized controlled trial.
    Diederichsen AC; Rasmussen LM; Søgaard R; Lambrechtsen J; Steffensen FH; Frost L; Egstrup K; Urbonaviciene G; Busk M; Olsen MH; Mickley H; Hallas J; Lindholt JS
    Trials; 2015 Dec; 16():554. PubMed ID: 26637993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The DanCavas Pilot Study of Multifaceted Screening for Subclinical Cardiovascular Disease in Men and Women Aged 65-74 Years.
    Kvist TV; Lindholt JS; Rasmussen LM; Søgaard R; Lambrechtsen J; Steffensen FH; Frost L; Olsen MH; Mickley H; Hallas J; Urbonaviciene G; Busk M; Egstrup K; Diederichsen ACP
    Eur J Vasc Endovasc Surg; 2017 Jan; 53(1):123-131. PubMed ID: 27890524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost effectiveness of population screening vs. no screening for cardiovascular disease: the Danish Cardiovascular Screening trial (DANCAVAS).
    Søgaard R; Diederichsen ACP; Rasmussen LM; Lambrechtsen J; Steffensen FH; Frost L; Egstrup K; Urbonaviciene G; Busk M; Lindholt JS
    Eur Heart J; 2022 Nov; 43(41):4392-4402. PubMed ID: 36029019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abdominal ultrasound-scanning versus non-contrast computed tomography as screening method for abdominal aortic aneurysm - a validation study from the randomized DANCAVAS study.
    Liisberg M; Diederichsen AC; Lindholt JS
    BMC Med Imaging; 2017 Feb; 17(1):14. PubMed ID: 28193267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cross-sectional study of aortic valve calcification and cardiovascular risk factors in older Danish men.
    Khurrami L; Møller JE; Lindholt JS; Urbonaviciene G; Steffensen FH; Lambrechtsen J; Karon M; Frost L; Busk M; Egstrup K; Fredgart MH; Diederichsen ACP
    Heart; 2021 Oct; 107(19):1536-1543. PubMed ID: 34376488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct and indirect healthcare costs of lung cancer CT screening in Denmark: a registry study.
    Jensen MD; Siersma V; Rasmussen JF; Brodersen J
    BMJ Open; 2020 Jan; 10(1):e031768. PubMed ID: 31969362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Baseline findings of the population-based, randomized, multifaceted Danish cardiovascular screening trial (DANCAVAS) of men aged 65-74 years.
    Lindholt JS; Rasmussen LM; Søgaard R; Lambrechtsen J; Steffensen FH; Frost L; Egstrup K; Urbonaviciene G; Busk M; Olsen MH; Hallas J; Diederichsen AC
    Br J Surg; 2019 Jun; 106(7):862-871. PubMed ID: 30919411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AI-based opportunistic CT screening of incidental cardiovascular disease, osteoporosis, and sarcopenia: cost-effectiveness analysis.
    Pickhardt PJ; Correale L; Hassan C
    Abdom Radiol (NY); 2023 Mar; 48(3):1181-1198. PubMed ID: 36670245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost effectiveness of screening for cardiovascular disease with measures of coronary calcium.
    Shaw LJ; Raggi P; Berman DS; Callister TQ
    Prog Cardiovasc Dis; 2003; 46(2):171-84. PubMed ID: 14505290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative effectiveness and cost-effectiveness of computed tomography screening for coronary artery calcium in asymptomatic individuals.
    van Kempen BJ; Spronk S; Koller MT; Elias-Smale SE; Fleischmann KE; Ikram MA; Krestin GP; Hofman A; Witteman JC; Hunink MG
    J Am Coll Cardiol; 2011 Oct; 58(16):1690-701. PubMed ID: 21982314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term Oncologic and financial implications of lung cancer screening.
    Pedersen JH; Sørensen JB
    Thorac Surg Clin; 2015 May; 25(2):223-9. PubMed ID: 25901566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of computed tomography for screening can be effective and safe.
    Giles J; Marshall J
    Br J Hosp Med (Lond); 2008 Jan; 69(1):6-7. PubMed ID: 18293720
    [No Abstract]   [Full Text] [Related]  

  • 15. Platelet aggregation is not altered among men with diabetes mellitus.
    Kring C; Rasmussen LM; Lindholt JS; Diederichsen ACP; Vinholt PJ
    Acta Diabetol; 2020 Apr; 57(4):389-399. PubMed ID: 31679079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of whole-body CT screening.
    Beinfeld MT; Wittenberg E; Gazelle GS
    Radiology; 2005 Feb; 234(2):415-22. PubMed ID: 15670999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct costs and cost-effectiveness of dual-source computed tomography and invasive coronary angiography in patients with an intermediate pretest likelihood for coronary artery disease.
    Dorenkamp M; Bonaventura K; Sohns C; Becker CR; Leber AW
    Heart; 2012 Mar; 98(6):460-7. PubMed ID: 21846767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The EOS 2D/3D X-ray imaging system: a cost-effectiveness analysis quantifying the health benefits from reduced radiation exposure.
    Faria R; McKenna C; Wade R; Yang H; Woolacott N; Sculpher M
    Eur J Radiol; 2013 Aug; 82(8):e342-9. PubMed ID: 23473735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical impact and cost-effectiveness of coronary computed tomography angiography or exercise electrocardiogram in individuals without known cardiovascular disease.
    Park GM; Kim SH; Jo MW; Her SH; Han S; Ahn JM; Park DW; Kang SJ; Lee SW; Kim YH; Lee CW; Kim BJ; Koh JM; Kim HK; Choe J; Park SW; Park SJ
    Medicine (Baltimore); 2015 May; 94(21):e917. PubMed ID: 26020405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Cost-Effectiveness Analysis of Lung Cancer Screening With Low-Dose Computed Tomography and a Diagnostic Biomarker.
    Toumazis I; Erdogan SA; Bastani M; Leung A; Plevritis SK
    JNCI Cancer Spectr; 2021 Dec; 5(6):. PubMed ID: 34738073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.